• Carmen Riley appointed as Managing Director, effective 1 March 2026
• Riley will continue in her current role as Chief Executive Officer
• David Collins to transition to Executive Director role

Paragon Care Limited (ASX: PGC), a leading healthcare wholesaler, distributor, and manufacturer throughout the Asia Pacific region, has announced the appointment of Carmen Riley as Managing Director, effective 1 March 2026. Riley will continue in her current role as Chief Executive Officer, a position she has held since 1 July 2025. This updated appointment is the next step in the leadership succession plan outlined in the Company's announcement dated 25 June 2025, and reflects the strong progress made by Riley since assuming the CEO role. Riley has continued to deliver operational improvements, advance the Company's integration program, and strengthen ParagonCare's strategic foundations as the business enters its next phase of growth. Riley has been with the broader organisation for more than 15 years, including as Chief Operating Officer / Executive Director following the merger with Clifford Hallam Healthcare Pty Ltd ('CH2') and in several senior roles within CH2 prior to that. As part of the transition, David Collins, who has served as Managing Director to date, will assume the role of Executive Director effective 1 March 2026. Collins will continue to contribute to ParagonCare's strategic agenda, including corporate development, merger and acquisition opportunities, and the completion of key integration initiatives.